449 related articles for article (PubMed ID: 37185833)
1. The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection.
Qudus MS; Tian M; Sirajuddin S; Liu S; Afaq U; Wali M; Liu J; Pan P; Luo Z; Zhang Q; Yang G; Wan P; Li Y; Wu J
J Med Virol; 2023 Apr; 95(4):e28751. PubMed ID: 37185833
[TBL] [Abstract][Full Text] [Related]
2. Helminth alleviates COVID-19-related cytokine storm in an IL-9-dependent way.
Cao Z; Wang J; Liu X; Liu Y; Li F; Liu M; Chiu S; Jin X
mBio; 2024 Jun; 15(6):e0090524. PubMed ID: 38727220
[TBL] [Abstract][Full Text] [Related]
3. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
4. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
Ramasamy S; Subbian S
Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
[TBL] [Abstract][Full Text] [Related]
5. Cytokines and microRNAs in SARS-CoV-2: What do we know?
Rarani FZ; Rashidi B; Jafari Najaf Abadi MH; Hamblin MR; Reza Hashemian SM; Mirzaei H
Mol Ther Nucleic Acids; 2022 Sep; 29():219-242. PubMed ID: 35782361
[TBL] [Abstract][Full Text] [Related]
6. Fighting the storm: could novel anti-TNFα and anti-IL-6
Kovalchuk A; Wang B; Li D; Rodriguez-Juarez R; Ilnytskyy S; Kovalchuk I; Kovalchuk O
Aging (Albany NY); 2021 Jan; 13(2):1571-1590. PubMed ID: 33465050
[TBL] [Abstract][Full Text] [Related]
7. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.
Wang J; Yang X; Li Y; Huang JA; Jiang J; Su N
Virol J; 2021 Jun; 18(1):117. PubMed ID: 34088317
[TBL] [Abstract][Full Text] [Related]
8. Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.
Gu T; Zhao S; Jin G; Song M; Zhi Y; Zhao R; Ma F; Zheng Y; Wang K; Liu H; Xin M; Han W; Li X; Dong CD; Liu K; Dong Z
Front Immunol; 2020; 11():621441. PubMed ID: 33584719
[TBL] [Abstract][Full Text] [Related]
9. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
10. The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19.
Makaremi S; Asgarzadeh A; Kianfar H; Mohammadnia A; Asghariazar V; Safarzadeh E
Inflamm Res; 2022 Aug; 71(7-8):923-947. PubMed ID: 35751653
[TBL] [Abstract][Full Text] [Related]
11. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
Ahmed F
Front Immunol; 2020; 11():590459. PubMed ID: 33362771
[TBL] [Abstract][Full Text] [Related]
12. The role of cytokines and their antagonists in the treatment of COVID-19 patients.
Mohseni Afshar Z; Barary M; Babazadeh A; Tavakoli Pirzaman A; Hosseinzadeh R; Alijanpour A; Allahgholipour A; Miri SR; Sio TT; Sullman MJM; Carson-Chahhoud K; Ebrahimpour S
Rev Med Virol; 2023 Jan; 33(1):e2372. PubMed ID: 35621229
[TBL] [Abstract][Full Text] [Related]
13. The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical).
Ghofrani Nezhad M; Jami G; Kooshkaki O; Chamani S; Naghizadeh A
J Interferon Cytokine Res; 2023 Apr; 43(4):147-163. PubMed ID: 37062817
[TBL] [Abstract][Full Text] [Related]
14. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
[TBL] [Abstract][Full Text] [Related]
15. Modulation of IRAK enzymes as a therapeutic strategy against SARS-CoV-2 induced cytokine storm.
Mahmoud IS; Jarrar YB; Febrimarsa
Clin Exp Med; 2023 Oct; 23(6):2909-2923. PubMed ID: 37061574
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 infection: an overview on cytokine storm and related interventions.
Montazersaheb S; Hosseiniyan Khatibi SM; Hejazi MS; Tarhriz V; Farjami A; Ghasemian Sorbeni F; Farahzadi R; Ghasemnejad T
Virol J; 2022 May; 19(1):92. PubMed ID: 35619180
[TBL] [Abstract][Full Text] [Related]
17. A systematic review on the effects of
Aucoin M; Cardozo V; McLaren MD; Garber A; Remy D; Baker J; Gratton A; Kala MA; Monteiro S; Warder C; Perciballi A; Cooley K
Metabol Open; 2021 Sep; 11():100115. PubMed ID: 34341776
[TBL] [Abstract][Full Text] [Related]
18. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
Front Immunol; 2021; 12():749291. PubMed ID: 34867978
[TBL] [Abstract][Full Text] [Related]
19. Cytokine Storm in COVID-19: Immunopathogenesis and Therapy.
Zanza C; Romenskaya T; Manetti AC; Franceschi F; La Russa R; Bertozzi G; Maiese A; Savioli G; Volonnino G; Longhitano Y
Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208467
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.
Shibabaw T
J Inflamm Res; 2020; 13():673-680. PubMed ID: 33116747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
